• Markets
    • icon
  • Companies
IDT · ASX

IDT Australia Limited (ASX:IDT)

AU$0.1

 -0.005 (-4.762%)
ASX:Live
06/12/2023 04:10:05 PM
HALO Price Momentum HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IDT Overview

IDT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IDT

Website

IDT Australia Limited

Telephone

61.3.9801.8888

Address

Boronia 45 Wadhurst Drive Melbourne, Victoria (VIC) 3155

Description

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle. It also provides services through API manufacturing, new drug development and scale-up, clinical research services, pharmacy services and finished dosage forms to the pharmaceutical industry. IDT Australia was founded by Graeme Leslie Blackman on October 14, 1975 and is headquartered in Melbourne, Australia.

IDT Price Chart

Key Stats

Market Cap

AU$36.91M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.12

Trade Value (12mth)

AU$4,797.00

1 week

-4.55%

1 month

41.89%

YTD

31.25%

1 year

20.69%

All time high

2.87019

Key Fundamentals

EPS 3 yr Growth

329.600%

EBITDA Margin

-126.00%

Operating Cashflow

-$8m

Free Cash Flow Return

-30.90%

ROIC

-33.20%

Interest Coverage

N/A

Quick Ratio

2.10

Other Data

Shares on Issue (Fully Dilluted)

251m

HALO Sector

Healthcare

Next Company Report Date

27-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IDT Announcements

Latest Announcements

Date Announcements

31 January 22

IDT Australia - Change of Auditor

×

IDT Australia - Change of Auditor

31 January 22

Sterile Readiness Agreement Update

×

Sterile Readiness Agreement Update

30 September 08

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 September 08

Annual Report to shareholders

×

Annual Report to shareholders

30 October 09

Managing Director Powerpoint Presentation

×

Managing Director Powerpoint Presentation

30 June 23

Notice of General Meeting/Proxy Form

×

Notice of General Meeting/Proxy Form

30 June 23

Proposed issue of securities - IDT

×

Proposed issue of securities - IDT

30 August 23

FY23 Full year profit results

×

FY23 Full year profit results

30 August 23

FY23 Full year results presentation

×

FY23 Full year results presentation

30 August 22

IDT Australia Appendix 4E 30 June 2022

×

IDT Australia Appendix 4E 30 June 2022

30 August 22

IDT Australia Appendix 4G 30 June 2022

×

IDT Australia Appendix 4G 30 June 2022

30 August 22

IDT Australia Corporate Governance Statement

×

IDT Australia Corporate Governance Statement

30 August 22

IDT Australia FY22 Annual Report

×

IDT Australia FY22 Annual Report

30 August 22

IDT Australia Investor Highlights 2022

×

IDT Australia Investor Highlights 2022

29 September 09

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 September 09

Annual Report to shareholders

×

Annual Report to shareholders

29 October 10

AGM Presentation

×

AGM Presentation

29 June 23

Ordinary Share Cancellations

×

Ordinary Share Cancellations

29 June 23

Notification of cessation of securities - IDT

×

Notification of cessation of securities - IDT

29 August 23

FY23 Appendix 4E and Annual Report

×

FY23 Appendix 4E and Annual Report

29 August 23

FY23 Appendix 4G and Corporate Governance Statement

×

FY23 Appendix 4G and Corporate Governance Statement

29 August 19

Annual Report to shareholders

×

Annual Report to shareholders

28 September 22

Appointment of Company Secretary and acting CFO

×

Appointment of Company Secretary and acting CFO

28 October 22

Interim CEO Contract Extension

×

Interim CEO Contract Extension

28 October 13

Investor Presentation Australia Biotech Invest 2013.

×

Investor Presentation Australia Biotech Invest 2013.

28 November 22

2022 AGM Chairman's Address

×

2022 AGM Chairman's Address

28 November 22

2022 AGM Presentation

×

2022 AGM Presentation

28 November 22

2022 AGM Results of Meeting

×

2022 AGM Results of Meeting

IDT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 -0.00 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 -0.00 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 208.6 -154.5 -625.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 0.04 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.01 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.1 336.7 -191.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.2 7.1 -53.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.12 0.12 0.08 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.12 0.12 0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.3 -1.8 -29.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 239 240 244 Lock Lock Lock
Basic m Lock Lock Lock Lock 239 240 244 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 16 12 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.4 -24.3 -42.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 5 5 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 5 3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 44.9 -42.2 -225.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 30.5 23.3 -50.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 69 77 151 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 0 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 264.2 -112.4 -2,469.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 17.2 -2.8 -126.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 2 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1 -2 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.5 -294.2 -421.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.0 -15.5 -141.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 1 -2 -10 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 -1 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 209.6 -155.2 -632.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 13.2 -9.6 -122.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 0 3 -8 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 4 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 2 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 94.1 1,349.4 -532.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.2 -1.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 9 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 30 28 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -6 -8 -4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 7 3 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 28 27 24 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 28 27 24 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.5 -2.3 -10.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 6.2 -3.9 -30.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.6 -4.3 -35.2 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 3.4 -6.7 -37.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 7.6 -4.2 -33.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 1.3 10.5 -30.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.2 24.5 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -22.3 -30.9 -15.3 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.8 5.0 2.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 2.8 4.6 2.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 40.1 66.5 45.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 6.1 103.0 -198.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.8 2.2 2.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 24.5 11.9 8.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.4 1.1 1.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 16.1 4.5 5.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.4 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.4 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.0 -15.5 -141.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.8 -6.2 -34.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -117.7 N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 6.2 -3.9 -30.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.1 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 7.6 -4.3 -35.2 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 7.6 -4.3 -35.2 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 14.9 30.6 43.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 197.5 165.2 135.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 212.4 195.8 178.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 84.8 57.5 15.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 127.6 138.2 163.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IDT Shortsell

Frequently Asked Questions

The current share price of IDT Australia Limited (IDT:ASX) is AU$0.1.
The 52-week high share price for IDT Australia Limited (IDT:ASX) is AU$0.12.
The 52-week low share price for IDT Australia Limited (IDT:ASX)? is AU$0.05.
IDT Australia Limited (IDT:ASX) does not pay a dividend.
The last dividend payment of IDT Australia Limited (IDT:ASX) is AU$0.01.
IDT Australia Limited (IDT:ASX) has a franking level of 0%.
IDT Australia Limited (IDT:ASX) is classified in the Healthcare.
The current P/E ratio for IDT Australia Limited (IDT:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.